Gray matter SWI-filtered phase and atrophy are linked to disability in MS

Jesper Hagemeier1, Bianca Weinstock-Guttman, Mari Heininen-Brown

  • 1Department of Neurology, School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, 100 High Street, Buffalo, NY 14203, USA.

Insights

Subcortical deep-gray matter (SDGM) atrophy and iron accumulation, measured by susceptibility-weighted imaging (SWI), are key indicators of disability in multiple sclerosis (MS) patients. These factors better predict disease progression than traditional MRI metrics.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease characterized by demyelination and neurodegeneration.
  • Subcortical deep-gray matter (SDGM) structures are increasingly recognized as critical sites of pathology in MS.
  • Susceptibility-weighted imaging (SWI) can detect iron deposition, a marker of neurodegeneration.

Purpose of the Study:

  • To investigate the association between SWI-filtered phase abnormalities (indicating iron content) and atrophy in the SDGM with clinical outcomes in MS patients.
  • To determine if SDGM pathology predicts disability progression better than conventional MRI metrics.

Main Methods:

  • 149 relapsing-remitting (RR) and 61 secondary-progressive (SP) MS patients underwent SWI on a 3T scanner.
  • Mean phase of the abnormal phase tissue (MP-APT) and normalized volumes were quantified for SDGM structures.
  • Age- and gender-adjusted regression models were used to assess the association with the Expanded Disability Status Scale (EDSS).

Main Results:

  • Total SDGM volume was the strongest predictor of EDSS (beta = -.224, p<.001), followed by total SDGM MP-APT (beta = -.168, p <.019).
  • SDGM MP-APT added significant variance in predicting EDSS beyond conventional MRI metrics.
  • Specific SDGM regions, including the caudate, red nucleus, and amygdala, showed associations between MP-APT/volume and EDSS.

Conclusions:

  • SDGM pathology, encompassing both atrophy and increased iron content (detected by SWI), is significantly associated with disability in MS patients.
  • These SWI-derived metrics offer a more sensitive measure of MS-related disability than lesion burden or white matter/cortical volumes.
  • SDGM iron content and atrophy are crucial imaging biomarkers for assessing clinical outcomes in MS.